The global oncology biosimilars market is witnessing rapid expansion due to the rising burden of cancer and increasing demand for cost-effective treatment alternatives. According to market insights, the oncology biosimilars market is expected to reach US$ 26,618 million by 2031, registering a CAGR of 16.3% during 2025–2031.
Biosimilars are biologic medical products highly similar to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt